Evidence map›Paper›PMID 38113104›Full record

ArticleJCI insight2024

Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa.

Margaret M Lowe, Jarish N Cohen, Madison I Moss, Sean Clancy, James P Adler, Ashley E Yates, Haley B Naik, Rashi Yadav, Mariela Pauli, Ian Taylor and 6 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 28 citations in OpenAlex.

  1. Mature tertiary lymphoid structures in pilonidal sinus disease.JID innovations : skin science from molecules to population health · 2026
    Article
  2. Article
  3. Germinal center responses at barrier organ sites.Current opinion in immunology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Inflammatory niches as spatial drivers of disease mechanisms and targets for personalized treatment.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Margaret M LoweDepartment of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.
Jarish N CohenDepartment of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.
Madison I MossDepartment of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.
Sean ClancyDepartment of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.
James P AdlerBioinformatics and Genomics master's program, University of Oregon, Eugene, Oregon, USA.
Ashley E YatesDepartment of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.
Haley B NaikDepartment of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.
Rashi YadavCancer Early Detection Advanced Research Center, Oregon Health & Science University (OHSU), Portland, Oregon, USA.
Mariela PauliTRex Bio, South San Francisco, California, USA.
Ian TaylorTRex Bio, South San Francisco, California, USA.
Austin McKayTRex Bio, South San Francisco, California, USA.
Hobart HarrisDepartment of Surgery, UCSF, San Francisco, California, USA.
Esther KimDepartment of Surgery, UCSF, San Francisco, California, USA.
Scott L HansenDepartment of Surgery, UCSF, San Francisco, California, USA.
Michael D RosenblumDepartment of Dermatology, University of California, San Francisco (UCSF), San Francisco, California, USA.
Joshua M MoreauCancer Early Detection Advanced Research Center, Oregon Health & Science University (OHSU), Portland, Oregon, USA.
University of California, San Francisco · USOregon Health & Science University · USTrex (United States) · US

Funding

Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GERMAN, MICHAEL S · 2003 to 2019
$21.8M
Restoring Immune Balance in Hiddradenitis SuppurativaR01AR075864 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSENBLUM, MICHAEL DAVID · 2020 to 2024
$3.5M
NIAMS NIH HHS R01 AR075864NIDDK NIH HHS P30 DK063720
6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) is a chronic skin condition affecting approximately 1% of the US population. HS skin lesions are highly inflammatory and characterized by a large immune infiltrate. While B cells and plasma cells comprise a major component of this immune milieu, the biology and the contribution of these cells in HS pathogenesis are unclear. We aimed to investigate the dynamics and microenvironmental interactions of B cells within cutaneous HS lesions. Combining histological analysis, single-cell RNA sequencing, and spatial transcriptomics profiling of HS lesions, we defined the tissue microenvironment relative to B cell activity within this disease. Our findings identified tertiary lymphoid structures (TLSs) within HS lesions and described organized interactions among T cells, B cells, antigen-presenting cells, and skin stroma. We found evidence that B cells within HS TLSs actively underwent maturation, including participation in germinal center reactions and class switch recombination. Moreover, skin stroma and accumulating T cells were primed to support the formation of TLSs and facilitate B cell recruitment during HS. Our data definitively demonstrated the presence of TLSs in lesional HS skin and point to ongoing cutaneous B cell maturation through class switch recombination and affinity maturation during disease progression in this inflamed nonlymphoid tissue.

Indexed as

Hidradenitis SuppurativaTertiary Lymphoid StructuresB-LymphocytesHumansSkinT-LymphocytesAdaptive immunityDermatologyImmunologySkin

Identifiers

PMID38113104
PMCPMC10967391
OpenAlexW4389976613

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.